MedPath

Randomized control study comparing quality of life after single-port versus conventional 3-port video-assisted thoracoscopic surgery

Phase 3
Conditions
primary lung cancer, metastatic lung cancer, benign tumor of the lung, pneumothorax
Registration Number
JPRN-UMIN000015340
Lead Sponsor
Center of Chest Medicine and Surgery, Ehime University Hospital
Brief Summary

In this prospective randomized controlled study comparing the efficacy of uniportal VATS with that of conventional 3-port VATS, the primary endpoint was not met, but it showed that pain on PODs 2, 3, 5, and 10 was mild, and the PSS was high. Thus, uniportal VATS is associated with improved levels of chest pain and patient satisfaction in the early stage postoperatively, without differences in complication rates and surgical margins from the lesions.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
84
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Severe pulmonary diseases (2) Respiratory tract infection (3) Severe circulatory diseases (4) When performing another operation concurrently (5) Obesity (BMI:Body Mass Index over 35) (6) Suspected cases of pregnancy (7) Patients with mental disorder or dementia (8) Patients who are judged ineligible by the investigator and the attending surgeon

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
degree of postoperative pain (POD 1, Numeric Rating Scale (NRS))
Secondary Outcome Measures
NameTimeMethod
intraoperative blood loss, duration of the surgical procedure, frequency of intraoperative and postoperative complications, distance from nodules or bullae to be resected to the edges, degree of postoperative pain (POD 2 to 5, Numeric Rating Scale (NRS)), frequency in use of analgesics, patient satisfaction score, postoperative pulmonary function, 6-munutes walk, CRP, WBC count, duration of drainage, postoperative hospital stay
© Copyright 2025. All Rights Reserved by MedPath